← Theranostic Atlas Therapy radar Imaging radar All targets Français Labeled leukocytes Ongoing clinical trials and approved products targeting Labeled leukocytes, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
0 ongoing therapy trials
0 ongoing imaging trials
2 approved products
Target note Full name Labeled autologous leukocytes Nature The patient's leukocytes are labeled in vitro, then reinjected, and migrate to sites of infection. Normal expression Spleen, liver, bone marrow. Value The reference for bone, joint and prosthetic infection. Approaches [99mTc]HMPAO-leukocytes, [111In]oxine-leukocytes. Indications explored Prosthetic infections, osteomyelitis, endocarditis, inflammatory bowel diseases. Points of caution Blood handling (dedicated radiopharmacy); physiological marrow uptake to be distinguished from infection. Approved products Labeled leukocytes ([99mTc]exametazime, [111In]oxine) [99mTc]exametazime, [111In]oxine Multiples marketed (national authorisations) US EU FR Scintimun [99mTc]besilesomab Telix Innovations marketed EU FR
Cite this page Labeled leukocytes. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/labeled-leukocytes/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.